CareFusion launches ChloraPrep 1 mL applicator

CareFusion (NYSE: CFN), a leading global medical technology company, today announced the launch of its ChloraPrep® 1 mL applicator, the newest addition to the ChloraPrep line of preoperative skin preparation products.

ChloraPrep 1 mL provides clinicians with a preferred applicator design and the same formulation as all other ChloraPrep applicators but in a new 1 mL size. The new size is ideal for procedures with an application area approximately 2.5 inches by 2.5 inches or smaller.

"The new ChloraPrep 1 mL applicator is an excellent extension of our ChloraPrep family of products, using the same formulation clinicians have come to know and trust," said Jan Creidenberg, vice president and general manager of Infection Prevention for CareFusion. "We continue to extend our skin prep leadership through our commitment to innovation and new product development to better meet our customers' needs."

With its unique delivery system and winged activation design, the 1 mL applicator is easy to use and can help promote aseptic technique and best practices. ChloraPrep skin prep products have been proven to be more effective than povidone-iodine at reducing microorganisms on the skin that may cause infection. ChloraPrep chlorhexidine products also have a low incidence of irritation and maintain their antimicrobial effectiveness in the presence of blood, unlike iodine-based products.




Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CareFusion Corporation. (2019, June 19). CareFusion launches ChloraPrep 1 mL applicator. News-Medical. Retrieved on December 10, 2019 from

  • MLA

    CareFusion Corporation. "CareFusion launches ChloraPrep 1 mL applicator". News-Medical. 10 December 2019. <>.

  • Chicago

    CareFusion Corporation. "CareFusion launches ChloraPrep 1 mL applicator". News-Medical. (accessed December 10, 2019).

  • Harvard

    CareFusion Corporation. 2019. CareFusion launches ChloraPrep 1 mL applicator. News-Medical, viewed 10 December 2019,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
FDA grants clearance for Breathe Technologies’ Non-Invasive Open Ventilation System